Articles
Cadillac's Pole Position Revoked at Daytona's Rolex 24 Amid Technical Inspection Failure
Action Express Racing's No. 31 Car Demoted Following Rear Skid Block Compliance Issue
During the lead-up to the Rolex 24 at Daytona, the Cadillac No. 31 entry from Action Express Racing initially secured pole position but was subsequent...
Hertz Extends Strategic Technology Partnership with Kyndryl to Accelerate Digital Transformation
The car rental leader commits to a five-year expansion with Kyndryl, harnessing AI and cloud migration to modernize operations and customer experience
Hertz Global Holdings has expanded its technology collaboration with Kyndryl Holdings through a five-year extension aimed at modernizing the company's...
2026 Grammy Awards Preview: Expert Analysis on Leading Nominees and Potential Winners
An in-depth look at the frontrunners and competitive categories at the upcoming 68th Grammy Awards
The 68th Grammy Awards feature a competitive field led by Kendrick Lamar with nine nominations followed by Lady Gaga, Jack Antonoff, and Cirkut with s...
Renée Fleming Withdraws from Kennedy Center Performances Amid Institutional Changes
Artist cancellations rise following leadership overhaul and planned venue renaming
Renowned soprano Renée Fleming has canceled two scheduled performances at the Kennedy Center in May. This decision aligns with a series of withdrawal...
Rocket Lab Achieves Milestone with 80th Electron Launch and Sets Course for Growth in 2026
Successful Deployment of Satellites Reinforces Rocket Lab’s Position Amid Ongoing Production Challenges
Rocket Lab successfully completed its first mission of 2026, marking the 80th Electron launch. The mission not only solidifies the company's standing ...
Datavault AI Encounters Stock Volatility Following Completion of API Media Acquisition
Shares initially rise on acquisition news but then decline amid mixed technical indicators
Datavault AI Inc. has finalized its acquisition of API Media Innovation Inc., aiming to broaden its data-monetization capabilities and extend its tech...
Mixed Movements in US Markets as Dow Declines Over 200 Points, Notable Stock Surges Amid Tech and Energy Dynamics
US equity markets display divergent trends with strong gains in select tech and energy sectors while the Dow experiences a pronounced pullback
On Friday, benchmark US stock indices showed mixed performance with the Dow Jones Industrial Average declining over 200 points despite gains in the NA...
Cardinal Health: Upgrade Trade — Buy the Business, Respect the Balance Sheet
Maintain a long swing position after the investment-grade reprieve and growing radiopharma exposure
Cardinal Health (CAH) just cleared two near-term investor fears: it held investment-grade credit standing and is visibly expanding into higher-margin ...
Meta Pullback = Opportunity: Buy the Re-acceleration Trade
Technical weakness has created a tactical entry on a fundamentally healthy cash machine with AI optionality.
Meta (META) pulled back from late-2025 strength into the mid-$600s. The business still generates huge operating cash flow, carries a fortress-like bal...
Atlantic International Advances Global Staffing Footprint with Circle8 Acquisition
The all-stock deal expands Atlantic's presence into European technology recruitment, diversifying its staffing portfolio across continents
Atlantic International Corporation has expanded its staffing services through the purchase of Europe's Circle8 Group, merging North American industria...
Key 2026 Medicare Updates Every Retiree Should Prepare For
Understanding increased premiums, new authorization rules, and telehealth restrictions shaping the Medicare landscape next year
Medicare, the federal health insurance program aiding U.S. seniors and certain disabled individuals since 1965, is undergoing notable changes beginnin...
Vaxcyte Advances VAX-31 Pneumococcal Vaccine Into Advanced Clinical Development
Phase 3 Trials Commence as Company Bolsters Manufacturing Investments for Future Growth
Vaxcyte, Inc. is progressing its next-generation pneumococcal vaccine candidate, VAX-31, by initiating Phase 3 trials targeting adult and infant popul...